CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 500 enrolled
Drug / intervention
Non-vitamin K antagonist oral anticoagulantdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03993119
NCT03993119N/ACompleted
CompareCT.gov

Non-Interventional, Cross-sectional Study to Describe NOACs Management in Elderly Patients With Non-valvular Atrial Fibrillation (NVAF) in Spain.

Boehringer Ingelheim·observational·Posted Jun 20, 2019·Updated Sep 29, 2021

In Brief

An observational study evaluating Non-vitamin K antagonist oral anticoagulant for Atrial Fibrillation. Completed, enrolled 500 participants across 45 sites.

Detailed Summary

This is an observational, multicenter and cross-sectional study in Non-valvular atrial fibrillation (NVAF) elderly patients currently on Non-vitamin K antagonist oral anticoagulant (NOAC) treatment for their stroke prevention.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAtrial Fibrillation
CountriesSpain
Collaborators--

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedJun 20, 2019
Enrollment StartJul 30, 2019
Primary CompletionAug 20, 2020
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 7.0 years ago

Interventions

Non-vitamin K antagonist oral anticoagulantdrug

Non-vitamin K antagonist oral anticoagulant